Osmosis Investment Management UK Ltd Purchases New Shares in Astera Labs, Inc. $ALAB

Osmosis Investment Management UK Ltd purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, HoldingsChannel.com reports. The firm purchased 3,723 shares of the company’s stock, valued at approximately $1,798,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Reflection Asset Management purchased a new stake in shares of Astera Labs in the fourth quarter valued at about $25,000. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs in the 2nd quarter valued at about $25,000. Smartleaf Asset Management LLC lifted its position in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in shares of Astera Labs in the fourth quarter valued at approximately $33,000. Finally, Whipplewood Advisors LLC raised its stake in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after purchasing an additional 319 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

Astera Labs stock opened at $277.53 on Tuesday. The firm’s 50-day moving average is $350.46 and its two-hundred day moving average is $246.41. The stock has a market capitalization of $48.15 billion, a P/E ratio of 137.39 and a beta of 3.84. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Activity at Astera Labs

In other news, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director owned 1,287,524 shares in the company, valued at $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 419,244 shares of company stock worth $163,135,169. Company insiders own 10.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ALAB. UBS Group restated a “neutral” rating and set a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Royal Bank Of Canada increased their target price on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Roth Capital reiterated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Bank of America upped their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Finally, Needham & Company LLC boosted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $333.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.